Publications
- Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Science
- Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
- Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene2016 | Faculty of Medicine in Pilsen, Faculty of Science
- Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study2016 | Faculty of Medicine in Pilsen
- Influence of IGF1 (insulin-like growth factor 1) signaling pathway to the development of cancer diseases2016 | Faculty of Medicine in Pilsen
- Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency2015 | First Faculty of Medicine
- Rare tumours of the heart – angiosarcomas2014 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case report2014 | Faculty of Medicine in Pilsen
- Erlotinib in the treatment of advanced squamous cell NSCLC2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC2013 | Faculty of Medicine in Pilsen
Loading network view...
